BioSpace News Archive

Biotech Beach

AVITA Medical Achieves Positive Topline Pivotal Trial Results for Treatment of Stable Vitiligo Using the RECELL® System

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company) today announced positive topline results from a pivotal randomized, controlled trial evaluating the safety and effectiveness of the RECELL® System for repigmentation of stable vitiligo lesions.

September 12, 2022
·
7 min read
Entera Bio to Present at H.C. Wainwright 24th Annual Global Investment Conference

Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today announced that the Company will present and host 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Investment Conference.

September 12, 2022
·
1 min read
Genetown

Sarepta Therapeutics Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes Due 2027

Sarepta Therapeutics, Inc. announced that it intends to offer, subject to market and other conditions, $1.0 billion aggregate principal amount of convertible senior unsecured notes that will mature on September 15, 2027, unless earlier redeemed, repurchased or converted.

September 12, 2022
·
9 min read
Pharm Country

Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13

Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference on September 13th at 4:30 p.m. Eastern time.

September 12, 2022
·
1 min read
Genetown

CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September 2022

CANbridge Pharmaceuticals, Inc. announced that it will be participating in two upcoming investor conferences.

September 12, 2022
·
2 min read
Deals

ADVANCED MEDTECH ACQUIRES WIKKON, STRENGTHENING ITS MARKET LEADING POSITION IN UROLOGY MEDICAL DEVICES

Integrated urology leader Advanced MedTech Holdings (AMTH or the Group) announced the acquisition of a majority interest in WIKKON, the Chinese market leader in urology and shock wave therapy devices.

September 12, 2022
·
4 min read
BioForest

Shape Therapeutics named one of Fierce Biotech’s “Fierce 15” Companies of 2022

Shape Therapeutics Inc. (ShapeTX), the RNA technology company advancing programmable medicine, today announced that Fierce Biotech has named it as one of 2022’s Fierce 15 biotechnology companies, designating it as one of the most promising early-stage biotechnology companies in the industry.

September 12, 2022
·
2 min read
Business

Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer

Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating PADCEV ® (enfortumab vedotin-ejfv) with KEYTRUDA ® (pembrolizumab) and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer.

September 12, 2022
·
61 min read
FDA

Brand Institute Partners on Brand Name and Nonproprietary Name Development for FDA Approved Injection for Frown Lines

Brand Institute is proud to announce its work with Revance Therapeutics in developing the brand name DAXXIFY™, which was approved by the FDA on September 7, 2022.

September 12, 2022
·
2 min read
Biotech Beach

Antech expands molecular diagnostic offerings in veterinary medicine’s most comprehensive diagnostics portfolio for canine cancer

Antech Diagnostics is advancing its leadership in canine cancer diagnostics to support early detection and personalized care pathways for dogs with cancer.

September 12, 2022
·
5 min read